Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 1
1990 1
1991 3
1992 1
1993 1
1994 2
1995 2
1996 2
1997 2
1998 2
1999 2
2000 1
2001 1
2002 2
2003 3
2004 3
2005 3
2006 3
2007 2
2008 1
2009 3
2010 5
2011 2
2012 1
2014 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

49 results
Results by year
Filters applied: . Clear all
Page 1
A lymphotoxin-beta-specific receptor.
Crowe PD, VanArsdale TL, Walter BN, Ware CF, Hession C, Ehrenfels B, Browning JL, Din WS, Goodwin RG, Smith CA. Crowe PD, et al. Science. 1994 Apr 29;264(5159):707-10. doi: 10.1126/science.8171323. Science. 1994. PMID: 8171323
The ligands and receptors of the lymphotoxin system.
Ware CF, VanArsdale TL, Crowe PD, Browning JL. Ware CF, et al. Among authors: crowe pd. Curr Top Microbiol Immunol. 1995;198:175-218. doi: 10.1007/978-3-642-79414-8_11. Curr Top Microbiol Immunol. 1995. PMID: 7774281 Review. No abstract available.
Brain-penetrating 2-aminobenzimidazole H(1)-antihistamines for the treatment of insomnia.
Coon T, Moree WJ, Li B, Yu J, Zamani-Kord S, Malany S, Santos MA, Hernandez LM, Petroski RE, Sun A, Wen J, Sullivan S, Haelewyn J, Hedrick M, Hoare SJ, Bradbury MJ, Crowe PD, Beaton G. Coon T, et al. Among authors: crowe pd. Bioorg Med Chem Lett. 2009 Aug 1;19(15):4380-4. doi: 10.1016/j.bmcl.2009.05.086. Epub 2009 May 27. Bioorg Med Chem Lett. 2009. PMID: 19553115
Influence of pKa on the biotransformation of indene H1-antihistamines by CYP2D6.
Huang C, Moree WJ, Zamani-Kord S, Li BF, Tucci FC, Malany S, Wen J, Wang H, Hoare SR, Yang C, Madan A, Crowe PD, Beaton G. Huang C, et al. Among authors: crowe pd. Bioorg Med Chem Lett. 2011 Feb 1;21(3):947-51. doi: 10.1016/j.bmcl.2010.12.053. Epub 2010 Dec 16. Bioorg Med Chem Lett. 2011. PMID: 21232954
Selectivity profiling of novel indene H(1)-antihistamines for the treatment of insomnia.
Li BF, Moree WJ, Yu J, Coon T, Zamani-Kord S, Malany S, Jalali K, Wen J, Wang H, Yang C, Hoare SR, Petroski RE, Madan A, Crowe PD, Beaton G. Li BF, et al. Among authors: crowe pd. Bioorg Med Chem Lett. 2010 Apr 15;20(8):2629-33. doi: 10.1016/j.bmcl.2010.02.055. Epub 2010 Feb 18. Bioorg Med Chem Lett. 2010. PMID: 20227880
Design and synthesis of tricyclic corticotropin-releasing factor-1 antagonists.
Gross RS, Guo Z, Dyck B, Coon T, Huang CQ, Lowe RF, Marinkovic D, Moorjani M, Nelson J, Zamani-Kord S, Grigoriadis DE, Hoare SR, Crowe PD, Bu JH, Haddach M, McCarthy J, Saunders J, Sullivan R, Chen T, Williams JP. Gross RS, et al. Among authors: crowe pd. J Med Chem. 2005 Sep 8;48(18):5780-93. doi: 10.1021/jm049085v. J Med Chem. 2005. PMID: 16134945
Lead optimization of 2-(piperidin-3-yl)-1H-benzimidazoles: identification of 2-morpholin- and 2-thiomorpholin-2-yl-1H-benzimidazoles as selective and CNS penetrating H₁-antihistamines for insomnia.
Ravula SB, Yu J, Tran JA, Arellano M, Tucci FC, Moree WJ, Li BF, Petroski RE, Wen J, Malany S, Hoare SR, Madan A, Crowe PD, Beaton G. Ravula SB, et al. Among authors: crowe pd. Bioorg Med Chem Lett. 2012 Jan 1;22(1):421-6. doi: 10.1016/j.bmcl.2011.10.115. Epub 2011 Nov 15. Bioorg Med Chem Lett. 2012. PMID: 22153347
The discovery and structure-activity relationships of 2-(piperidin-3-yl)-1H-benzimidazoles as selective, CNS penetrating H1-antihistamines for insomnia.
Lavrador-Erb K, Ravula SB, Yu J, Zamani-Kord S, Moree WJ, Petroski RE, Wen J, Malany S, Hoare SR, Madan A, Crowe PD, Beaton G. Lavrador-Erb K, et al. Among authors: crowe pd. Bioorg Med Chem Lett. 2010 May 1;20(9):2916-9. doi: 10.1016/j.bmcl.2010.03.027. Epub 2010 Mar 10. Bioorg Med Chem Lett. 2010. PMID: 20347297
49 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page